I agree that this site is using cookies. You can find further informations here.
X
Giuseppe Auteri
125  results:
Search for persons X
?
1

Sustained response off therapy after fostamatinib: A chroni..:

Auteri, Giuseppe ; Biondo, Mattia ; Mazzoni, Camilla...
Heliyon.  9 (2023)  2 - p. e13462 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Determinants of Covid19 disease and of survival after Covid..:

Palandri, Francesca ; Elli, Elena M. ; Auteri, Giuseppe...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
3

Predictors of Response to Hydroxyurea and Switch to Ruxolit..:

Palandri, Francesca ; Rossi, Elena ; Auteri, Giuseppe...
Cancers.  15 (2023)  14 - p. 3706 , 2023
Link: https://doi.org/10.3390/..
 
?
4

Incidence of blast phase in myelofibrosis patients accordin..:

Palandri, Francesca ; Palumbo, Giuseppe A. ; Benevolo, Giulia...
Cancer.  130 (2023)  8 - p. 1270-1280 , 2023
Link: https://doi.org/10.1002/..
 
?
5

Ruxolitinib in cytopenic myelofibrosis: Response, toxicity,..:

Palandri, Francesca ; Breccia, Massimo ; Mazzoni, Camilla...
Cancer.  129 (2023)  11 - p. 1704-1713 , 2023
Link: https://doi.org/10.1002/..
 
?
6

P1601: PREDICTING THE RESPONSE TO SPLENECTOMY IN IMMUNE THR..:

Zoletto, Simone ; Pizzi, Marco ; Andrea, De Crescenzo...
HemaSphere.  7 (2023)  S3 - p. e05638b6 , 2023
Link: https://doi.org/10.1097/..
 
?
7

A Prognostic Model to Predict Ruxolitinib Discontinuation a..:

Palandri, Francesca ; Palumbo, Giuseppe A. ; Bonifacio, Massimiliano...
Cancers.  15 (2023)  20 - p. 5027 , 2023
Link: https://doi.org/10.3390/..
 
?
8

P1028: MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX) MO..:

Palandri, Francesca ; Auteri, Giuseppe ; Iurlo, Alessandra...
HemaSphere.  7 (2023)  S3 - p. e4692509 , 2023
Link: https://doi.org/10.1097/..
 
?
9

IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID1..:

Auteri, Giuseppe ; Paglia, Simona ; Mazzoni, Camilla...
Mediterranean Journal of Hematology and Infectious Diseases.  15 (2023)  1 - p. e2023029 , 2023
Link: https://doi.org/10.4084/..
 
?
10

Refractory primary immune thrombocytopenia (ITP): current c..:

Vianelli, Nicola ; Auteri, Giuseppe ; Buccisano, Francesco...
Annals of Hematology.  101 (2022)  5 - p. 963-978 , 2022
Link: https://doi.org/10.1007/..
 
?
11

Thrombopoietin receptor agonists increase splenic regulator..:

Pizzi, Marco ; Vianello, Fabrizio ; Binotto, Gianni...
British Journal of Haematology.  198 (2022)  5 - p. 916-922 , 2022
Link: https://doi.org/10.1111/..
 
?
12

Prediction of thrombosis in post-polycythemia vera and post..:

Mora, Barbara ; Guglielmelli, Paola ; Kuykendall, Andrew...
Leukemia.  36 (2022)  10 - p. 2453-2460 , 2022
Link: https://doi.org/10.1038/..
 
?
13

Deferasirox in the management of iron overload in patients ..:

Elli, Elena Maria ; Di Veroli, Ambra ; Bartoletti, Daniela...
British Journal of Haematology.  197 (2022)  2 - p. 190-200 , 2022
Link: https://doi.org/10.1111/..
 
?
14

Longer-term response to SARS-CoV-2 vaccine in MPN patients:..:

Auteri, Giuseppe ; Bartoletti, Daniela ; Di Pietro, Christian...
Leukemia Research.  116 (2022)  - p. 106819 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Peripheral blasts are associated with responses to ruxoliti..:

Palandri, Francesca ; Bartoletti, Daniela ; Iurlo, Alessandra...
Cancer.  128 (2022)  13 - p. 2449-2454 , 2022
Link: https://doi.org/10.1002/..
 
1-15